Kim et al. [24] reported on increasing frequency of Ki67 + cells within CD8 + PD-1 + T-cells in patients with locally advanced NSCLC during cCRT peaking at the last week during therapy followed by a decline 1-mo post-cCRT. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.